Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 79

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 79
---
 Cayman Islands company ordinarily have dissenters’ rights with respect to a statutory merger. The Cayman Companies Act prescribes when shareholder dissenters’ rights will be available and sets the limitations on such rights. Where such rights are available, shareholders are entitled to receive fair value for their shares. However, regardless of whether such rights are or are not available, APx’s shareholders are still entitled to exercise the rights of redemption as detailed in this proxy statement/prospectus and the APx Board has determined that the redemption proceeds payable to APx’s shareholders who exercise such redemption rights represents the fair value of those shares. Proxy Solicitation Proxies may be solicited by mail, telephone or in person. APx has engaged [•] to assist in the solicitation of proxies. If a shareholder grants a proxy, it may still vote its shares in person (which would include presence online at the Special Meeting) if it revokes its proxy before the Special Meeting. A shareholder also may change its vote by submitting a later -datedproxy as described in the section entitled “ Special Meeting of the Shareholders — Revoking Your Proxy.” Interests of Certain Persons in the Business Combination In considering the recommendation of the APx Board to vote in favor of the Business Combination, shareholders should be aware that, aside from their interests as shareholders, our Initial Shareholders and our directors, officers and advisors and the Company’s current shareholders have interests in the Business Combination that are different from, or in addition to, those of our other shareholders generally. Our directors were aware of and considered these interests, among other matters, in evaluating the Business Combination, and in recommending to our shareholders that they approve the Business Combination. Shareholders should take these interests into account in deciding whether to approve the Business Combination. These interests include, among other things: •the Initial Shareholders will lose their entire investment in APx if APx does not complete an initial business combination by the Extended Date; •the beneficial ownership of the Initial Shareholders of an aggregate of 4,312,500 SPAC Class A Ordinary Shares comprised of 3,342,188 SPAC Class A Ordinary Shares held by the Sponsor (which shares were purchased in connection with the Sponsor Alliance) and 970,312 SPAC Class A Ordinary Shares held by the Initial Sponsor (which were purchased in connection with the IPO and which were retained in connection with the Sponsor Alliance). Such shares have an aggregate market value of approximately $39,571,506 million based on the closing price of the Public Shares of $11.